Acute Kidney Injury Treatment Market Size, Share, Trends, & Forecast Report by 2032

Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market By Injury Type (Squamous Cell (Epidermoid) Carcinoma, Adenocarcinoma, Large Cell (Undifferentiated) Carcinoma And Other), By Therapy (Chemotherapy, Radiotherapy, Laser Therapy, Photodynamic Therapy (PDT) And Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-5128 Published Date: May-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1687.49 Million USD 3,401.52 Million 8.10% 2023

Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market: Size

The global acute kidney injury treatment market size was worth around USD 1687.49 million in 2023 and is predicted to grow to around USD 3,401.52 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.10% between 2024 and 2032.

The report covers forecast and analysis for the Acute Kidney Injury Treatment market on a global and regional level. The study provides historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million).
Global Acute Kidney Injury Treatment Market SizeRequest Free Sample

Acute Kidney Injury Treatment Market: Overview

The study includes drivers and restraints for the Acute Kidney Injury Treatment market along with the impact they have on the demand over the forecast period.

Additionally, the report includes the study of opportunities available in the Acute Kidney Injury Treatment market on a global level. In order to give the users of this report a comprehensive view on the Acute Kidney Injury Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Injury Type, therapy, distribution channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

The Acute Kidney Injury treatment market is expected to grow with a multi-faceted quality improvement program to improve acute kidney injury care. Acute kidney injury is becoming more prevalent in both developed and developing countries. Government awareness-raising efforts by introducing various Acute Kidney Injury services are expected to fuel the growth of the treatment industry. It is expected that the medical or healthcare sector will drive Acute Kidney Injury market growth. Side effects of drugs, however, hamper market growth.

Severe inflammation and damage to the kidney is acute kidney injury. Acute kidney damage leads to sudden kidney function failure and changes in the status of waste products, electrolytes and weight. Acute kidney injury is essentially a medical emergency related to adverse clinical outcomes. This is a syndrome with many different causes characterized by a rapid loss of renal function resulting in failure to maintain volume, fluids, electrolytes, and acid-base balance.

Acute kidney injury is a common syndrome linked to increased mortality. Detection of acute kidney injury based on the level of serum creatinine, assessment of urine output. Acute kidney injury occurs with frail older people being particularly vulnerable in many different medical and surgical specialties. Bacterial blood infection is the common cause of a disease, and other causes include heart surgery, toxic medications, or liquids and injuries from surgical contrast. Acute kidney damage in the body decreases the level of alkaline phosphatase.

Acute Kidney Injury Treatment Market: Segmentation

The study provides a decisive view on the Acute Kidney Injury Treatment market by segmenting the market based on Injury Type, Therapy, Distribution Channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on Injury Type, the market is segmented into   Pre-renal, Intrinsic renal and Post-renal. The pre-renal acute kidney injury segment held a leading role in the global market for acute kidney injury treatment in 2018 in terms of type. It is expected to gain market share by the end of 2027, in the acute kidney injury care market.

Based on the Therapy segment, the market is bifurcated Intermittent hemodialysis, Continuous renal replacement therapy and Sustained low-efficiency dialysis.  

Based on the Distribution Channel segment, the market is bifurcated into Hospital pharmacies, Online pharmacies and Others. The distribution channel group for hospital pharmacies will have a significant share over the coming years. Hospital pharmacies typically store a large number of drugs and advanced equipment and provide hospital patients with medication. The burden of genetic disorder would increase the number of hospitalizations, thereby having a positive effect on hospital pharmaceutical development.

Acute Kidney Injury Treatment Market: Report Scope

Report Attributes Report Details
Report Name Acute Kidney Injury Treatment Market Research Report
Market Size in 2023 USD 1687.49 Million
Market Forecast in 2032 USD 3,401.52 Million
Growth Rate CAGR of 8.10%
Number of Pages 130
Key Companies Covered Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem. amongst others.
Segments Covered By Injury Type, By Therapy, By Distribution, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Acute Kidney Injury Treatment Market: Regional Analysis

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America's rise in disease-oriented drug research and availability of both approved and symptomatic treatment for acute kidney injury is expected to dominate the global market for treatment of acute kidney injury.

It is expected that Europe will be the second most lucrative therapeutic market for acute kidney injury due to improved quality of healthcare services and increased acceptance of treatment in this area. Due to the large pool of patients and rising investment in better healthcare facilities, Asia-Pacific is projected to be the fastest growing region for treatment of acute kidney injury.

Approx. 700,000 deaths were associated with acute kidney injury in Europe, the United States and Japan. It is expected that increased awareness of the acute kidney injury would expand the treatment demand. Market for acute kidney injury treatment is enhancing the renal ultrasonography needed to search for reversible cause of acute kidney injury such as kidney stone obstruction. Ultrasonography of the renal helps identify ischemic acute kidney damage and decreased blood flow of the renal. Acute kidney damage is now widely recognized as a serious problem in health care for a few days.

Acute Kidney Injury Treatment Market: Leading Players

Some of the leading players in the global market include

  • Angion Biomedica Corp.
  • AM-Pharma
  • Quark Pharmaceuticals Inc.
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA.
  • B. Braun Melsungen AG
  • Asahi Kasei Medical Co. Ltd.
  • LG Chem

The report segments global Acute Kidney Injury Treatment market as follows:

By Injury Type Segment Analysis

  • Pre-renal
  • Intrinsic renal
  • Post-renal

By Therapy Segment Analysis

  • Intermittent hemodialysis
  • Continuous renal replacement therapy
  • Sustained low-efficiency dialysis

By Distribution Channel Segment Analysis

  • Hospital pharmacies
  • Online pharmacies
  • Others

By Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Acute kidney injury (AKI) is a sudden decline in kidney function, often occurring within a few hours or days. The treatment of AKI focuses on managing the underlying cause, supporting kidney function, and preventing complications.

According to study, the global Acute Kidney Injury Treatment Market size was worth around USD 1687.49 million in 2023 and is predicted to grow to around USD 3,401.52 million by 2032.

The CAGR value of Acute Kidney Injury Treatment Market is expected to be around 8.10% during 2024-2032.
 

North America has been leading the global Acute Kidney Injury Treatment Market and is anticipated to continue on the dominant position in the years to come.

The global Acute Kidney Injury Treatment Market is led by players like Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals Inc., Baxter International Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., LG Chem.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed